0161-5890
Semimonthly
No
MOL IMMUNOL
1979
250
ENGLAND
http://www.journals.elsevier.com/molecular-immunology/
约2.0个月审稿时间
约62.5%平均录用比例
3.064影响因子
生化与分子生物学小学科
月期刊平台服务过的文章录用时间为1-3个月,依据20年经验,经月期刊专家预审通过后的文章,投稿通过率100%以上!
分子免疫学主要致力于在分子水平上描述免疫学知识的发表。在这一框架内包括了有关细胞成分和过程的分子分析的贡献,这些成分和过程是细胞参与免疫现象的生理行为的基础。仅仅描述新的单克隆抗体和/或表位图的论文将不再被接受,除非它们与对免疫系统的理解有直接关系。在分子免疫学中,各种形式的通讯将如下:研究报告。这些构成了通讯的主要类别。每一份报告都包括对研究问题、实验方法和结果的详细和完整描述。它必须提供新的和重要的知识,并载有其他实验室核查结论所必需的资料。手稿要经过专家审稿人的详细审查,他们的建议是决定出版可接受性的主要因素。经区域编辑委员会同意,作为“小型专题讨论会”的研究报告小组也可由客座编辑组织。这些报告也将受到严格审查。预期在选定的领域发表这类邀请的论文组,可促进最近出现的领域的新空缺,并鼓励个人在这些新领域作出贡献。简短的沟通。为了在分子免疫学领域提供及时而有意义的观察结果的快速传播,该杂志将以原稿(2或4页)的摄影复制形式发表简短的通讯。这些手稿也将由专家进行评估。
http://ees.elsevier.com/mimm/
Molecular Immunology is primarily devoted to the publication of immunological knowledge which can be delineated at the molecular level. Within this framework are included contributions concerned with the molecular analysis of the cellular components and processes which underlie the physiological behavior of cells involved in immune phenomena. Papers which merely describe new monoclonal antibodies and/or epitope mapping will no longer be accepted unless they have a direct relevance to the understanding of the immune system. The various forms of communications in Molecular Immunology will be as follows: Research Reports. These constitute the major category of communications. Each report consists of a detailed and complete description of the research problem, the experimental approach and the findings. It must provide new and significant knowledge and contain the information essential for verification of conclusions by other laboratories. Manuscripts are subject to detailed scrutiny by expert reviewers whose recommendations are the primary determinants of acceptability for publication. Groups of research reports as 'mini symposia' may also be organized by a Guest Editor, in agreement with the board of Regional Editors. Such reports will also be subject to critical review. It is anticipated that the publication of such invited groups of papers in selected areas may promote new openings in recently emerging fields and encourage individual contributions in these new areas. Short Communications. To provide rapid dissemination of timely and significant observation in molecular immunology, the journal will publish short communications in the form of a photographic reproduction of the original manuscript (2 or 4 pages). These manuscripts will also be evaluated by experts.
快速预审、投刊前指导、专业学术评审,对文章进行评价;
立即咨询校对编辑、深度润色,让稿件符合学术规范,格式体例等标准;
立即咨询适用于语句和结构尚需完善和调整的中文文章,确保稿件达到要求;
立即咨询数据库包括:期刊、文章、书籍、会议、预印书、百科全书和摘要等;
立即咨询让作者在期刊选择时避免走弯路,缩短稿件被接收的周期;
立即咨询根据目标期刊格式要求对作者文章进行全面的格式修改和调整;
立即咨询帮助作者将稿件提交至目标期刊投稿系统,降低退稿或拒稿率;
立即咨询按照您提供的稿件内容,指导完成投稿附信(cover letter);
立即咨询大类学科同领域优质期刊 | 大类学科 | 小类学科 | 影响因子 | 分区 | ISSN |
---|---|---|---|---|---|
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 医学 | 生化与分子生物学 | 6.887 | N/A | 0304-419X |
BIOORGANIC & MEDICINAL CHEMISTRY | 医学 | 生化与分子生物学 | 2.802 | 3区 | 0968-0896 |
Chemical Biology & Drug Design | 医学 | 生化与分子生物学 | 2.256 | 4区 | 1747-0277 |
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY | 医学 | 生化与分子生物学 | 2.697 | N/A | 1532-0456 |
CURRENT DRUG METABOLISM | 医学 | 生化与分子生物学 | 2.277 | 3区 | 1389-2002 |
INFECT MED | 医学 | 生化与分子生物学 | N/A | 3区 | 0929-8673 |
MED ORAL PATOL ORAL | 医学 | 生化与分子生物学 | N/A | N/A | 0957-9672 |
CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 医学 | 生化与分子生物学 | 1.516 | N/A | 1389-2010 |
CYTOKINE | 医学 | 生化与分子生物学 | 3.078 | 3区 | 1043-4666 |
EXPERIMENTAL AND MOLECULAR MEDICINE | 医学 | 生化与分子生物学 | 4.743 | 2区 | 1226-3613 |
发现心仪选题请填单
获取发表周期短、审稿速度快容易录用的期刊